Journal of Clinical Infectious Diseases & Practice
Open Access
Pertussis Vaccines
Search results for
Pertussis Vaccines
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 525
Journal of Clinical Infectious Diseases & Practice peer review process verified at publons
Indexed In
- Google Scholar
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- ICMJE
Useful Links
Share This Page
Pertussis Vaccines
Pertussis vaccine is given in combination with diphtheria (D) and tetanus (T) toxoids and pertussis (P) vaccine. Denoted as DTaP vaccine. DTaP vaccine is given to Children in five doses, one dose at each of the following ages: 2 months, 4 months, 6 months, 15 through 18 months, and 4 through 6 years. Tdap is a tetanus, diphtheria, and pertussis vaccine given to preteens, teens, and adults as a one-time shot, or after exposure to tetanus.
Related Journals for Pertussis Vaccines
Journal of Clinical Infectious Diseases & Practice, Journal of Infectious Diseases & Therapy, Journal of Bacteriology & Parasitology, Journal of Medical Microbiology & Diagnosis, Journal of Medical Diagnostic Methods, Expert Review of Vaccines, Human Vaccines, Genetic Vaccines and Therapy, Human Vaccines and Immunotherapeutics, Journal of Immune Based Therapies and Vaccines, Journal of Vaccines and Vaccination, Zhongguo ji hua mian yi = Chinese journal of vaccines and immunization, Vaccines: Children and Practice, Vaccine & immunization news : the newsletter of the Global Programme for Vaccines and Immunization.
Pertussis Vaccines
Speaker PPTs
- Ganesh Raj Pant
A serological study in response to people at occupational risk of rabies virus exposure in Nepal
PPT Version | PDF Version - Daniela Pencheva
BUL BIO-NCIPD
PPT Version | PDF Version - Wendy peters
A non-replicating Ad5 vaccine for treatment of HSV-2
PPT Version | PDF Version - Randa Hamadeh
Polio returns to Middle East, situation analysis, strategies and way forward
PPT Version | PDF Version - Luiza Guilherme
Streptococcus pyogenes candidate vaccine
PPT Version | PDF Version - Xiao-Song He
Distinct priming effect of live attenuated versus inactivated influenza vaccines in repeated influenza vaccination
PPT Version | PDF Version - Stephanie Ramos
Enhanced Delivery of Dna-Based Vaccines and Immunotherapeutics through Next-Generation Electroporation Devices
PPT Version | PDF Version - Manoj Kumar Chhikara
How promising is the development of a semi-synthetic meningococcal conjugate vaccine ?
| PDF Version - Charani ranasinghe
Unique IL-4R antagonist and IL-13Ra2 adjuvanted pox viral vector-based HIV vaccines
PPT Version | PDF Version - Sourav Sarkar
MUC1 glycopeptide based anti-cancer vaccines
PPT Version | PDF Version - Robert Lambkin-Williams
Accelerating influenza research; Vaccines, antivirals, immunodulators and monoclonal antibodies. The manufacture of a new H3N2 virus for the human viral challenge model
PPT Version | PDF Version - Didier Betbeder
Nasal administration of antigens using maltodextrin nanoparticles: a mechanistic study
PPT Version | PDF Version - Carmen Alvarez-Dominguez
A dendritic cell targeted vaccine loaded with a GAPDH peptide confers wide protection to listeriosis in susceptible and resistant mice
| PDF Version - Zakaria Hmama
A non-genetic approach to improve the tuberculosis vaccine BCG
PPT Version | PDF Version - Filip Dubovsky
Development of a passive RSV vaccine for infants as an alternative to maternal vaccination
| PDF Version - Fu Shi Quan
Influenza virus-like particle vaccines elicit protective immunity in the early stage of vaccination
PPT Version | PDF Version - De-chu Christopher Tang
Activation of protective innate-adaptive immunity duo for conferring rapid-sustained-broad protection of vaccines against infectious agents
PPT Version | PDF Version - Poonam Salotra
Development of genetically modifi ed live attenuated parasites as potential vaccines against visceral leishmaniasis
PPT Version | PDF Version - Ligia A. Pinto
Immune Responses to Human Papillomavirus Vaccines: What We Have Learned
PPT Version | PDF Version